Dr. Kris Discusses Tests Available for Lung Cancer

Mark G. Kris, MD
Published: Tuesday, Jun 28, 2011

Mark G. Kris, MD, the chief of Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses tests available for lung cancer patients.

Dr. Kris says the vast majority of tests are for mutations. He says FISH is a poor cousin of mutation and that virtually all mutated patients are FISH positive. Tests for mutations are more potent predictors and most trials use them. Some of the tests are done by FISH test. They look for MET amplifications and EML4-ALK as a FISH test.
Mark G. Kris, MD, the chief of Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses tests available for lung cancer patients.

Dr. Kris says the vast majority of tests are for mutations. He says FISH is a poor cousin of mutation and that virtually all mutated patients are FISH positive. Tests for mutations are more potent predictors and most trials use them. Some of the tests are done by FISH test. They look for MET amplifications and EML4-ALK as a FISH test.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x